Associations between multiple myeloma and other malignancies

Leukemia and Lymphoma

Volumn 52, Issue 2, 2011, Pages 161-162

  Landgren, Ola ^a   Polliack, Aaron ^b   Tadmor, Tamar ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MELPHALAN; NITROSOUREA;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE ASSOCIATION; GYNECOLOGIC CANCER; HEMATOPOIETIC STEM CELL; HUMAN; IONIZING RADIATION; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NOTE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SOLID TUMOR; UTERINE CERVIX CANCER;

HUMANS; INCIDENCE; MULTIPLE MYELOMA; NEOPLASMS, MULTIPLE PRIMARY; PROGNOSIS; SURVIVAL RATE;

EID: 79551646037     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.538942     Document Type: Note

References (9)

1. Hasskarl J, Ihorst G, De Pasquale D, et al. Association of multiple myeloma with different neoplasms: systematic analysis in consequtive patients with myeloma. Leuk Lymphoma 2010;51; 247-259.
2. Barlogie B, Tricot G, Haessler J, et al. Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989. Blood 2008;111:94-100.
3. Kaldor JM, Day NE, Clarke EA, et al. Leukemia following Hodgkin's disease. N Engl J Med 1990;322:7-13.
4. Shulman LN. The biology of alkylating-agent cellular injury. Hematol Oncol Clin North Am 1993;7:325-335.
5. Niparuck P, Kanoksil W, Chuncharunee S, et al. Therapyrelated myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients. Leuk Lymphoma 2010 Sep 17 [Epub ahead of print].
6. Carney DA, Seymour JF. Therapy-related myelodysplasia and fludarabine combination therapy for patients with indolent non- Hodgkin lymphoma and chronic lymphocytic leukemia - do the benefits justify the risk? Leuk Lymphoma 2010;11:1957-1959.
7. Carney DA, Westerman DA, Tam CS, et al. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy. Leukemia 2010 Oct 21. [Epub ahead of print].
8. Curtis RE, Freedman MD, Ron E, et al. New malignancies among cancer survivors: SEER cancer registries, 1973-2000. Bethesda: National Cancer Institute, NIH; 2006.
9. Turesson I, Velez R, Kristinsson SY, Landgren O. Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study. J Clin Oncol 2009;28:830-834.